Scott Tarriff

Scott Tarriff's bio

Founder, President and Chief Executive Officer, Director
Board Member, Penn State Smeal College of Business Board of VisitorsScott Tarriff.jpg

Scott Tarriff '81 leads Eagle Pharmaceuticals, Inc. with more than 25 years of industry experience. Scott founded Eagle in 2007 with the objective of utilizing the 505(b)(2) pathway to maximize the potential of proven medicines. Prior to founding the company, Scott held several key executive‐level positions at publicly traded companies, including Bristol‐Myers Squibb and Par Pharmaceutical. Scott quickly rose through the ranks at Bristol‐Myers Squibb prior to joining Par. While at Par, he served as President and Chief Executive Officer from 2003 to 2006 and served on the board of directors from 2002 to 2006.

Scott currently sits on the board of directors of Synthetic Biologics, Inc., Ziopharm Oncology, Inc., Hackensack Meridian Health, and Hackensack University Medical Center. He previously served on the board of directors of Clinical Data, Inc., a publicly traded pharmaceutical company, from 2009 to 2011, during its acquisition by Forest Laboratories, Inc. In 2016, Scott was awarded the prestigious Ernst and Young Entrepreneur Of The Year® Award in the Specialty Pharmaceutical category, New Jersey. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in areas such as
innovation, financial performance, and personal commitment to their businesses and communities.

Scott holds a BS in marketing from Pennsylvania State University and an MBA from Rider College.